Clot-busting enzymes are working two jobs

The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.

In research published today in Cell Reports, scientists from Monash University have demonstrated for the first time the enzyme t-PA, which plays a vital role in the removal of clots, is also a major player in the removal of necrotic, or dead, cells.

occurs when cells in living tissue die prematurely due to external stress or injury. The body's system for removing waste associated with necrotic cell removal was not, until now, well understood.

Professor Robert Medcalf and Dr Andre Samson, of the University's Australian Centre for (ACBD), led the research with Professor Stephen Bottomley of the Monash Department of Biochemisty and .

The research team found that in the late stages of death, the injured cell undergoes a restructure and takes on a form not unlike a blood clot, to prepare for efficient removal from the body. This process had never been described before.

Professor Medcalf said the blood clot-like structure allowed the damaged cells to be recognised and removed by t-PA and its enzymatic waste disposal team.

"It's exactly the same principle as the formation and removal of a blood clot," Professor Medcalf said.

"In the process of a cell dying it goes through this unique form of aggregation to keep all the intracellular debris localised. Then, it can be taken out in an orderly fashion by the blood clot-busting enzyme system without causing damage to the body."

The researchers were studying when they made the discovery, but have shown that the same process applies to every cell in the body.

"It's very efficient. Instead of doubling up, the body is using the same disposal system to eliminate a variety of unwanted waste products, be they or that have served their purpose," Professor Medcalf said.

"What this means is that t-PA and its team of enzymes recognises waste through structure or shape, not by the specific proteins involved."

The findings shed further light on the function and therapeutic uses of t-PA, which is used in the treatment of stroke and heart attack.

Researchers from Alfred Health and the Ludwig Institute for Cancer Researchers also collaborated on the study, which was funded by the National Health and Medical Research Council of Australia.

Related Stories

Clot-busting enzyme plays 'peek-a-boo' with blood clots

Mar 08, 2012

By discovering how a blood clot-busting enzyme is switched on, researchers have unlocked a century-old atomic riddle that could lead to new treatments for clotting and bleeding disorders, and some cancers.

Research sheds new light on how blood clots form

Jun 13, 2011

Scripps Research Institute scientists have discovered new elements of the blood clot-formation process. The findings could lead to better drugs for preventing heart attacks and other clot-related conditions.

Substance in cancer medicine could prevent heart attacks

Nov 23, 2011

A substance in medicines for cancer and epilepsy could also prevent heart attacks, according to researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, who have been using it to stimulate ...

Solving the mystery of blood clotting

Mar 19, 2012

How and when our blood clots is one of those incredibly complex and important processes in our body that we rarely think about. If your blood doesn't clot and you cut yourself, you could bleed to death, if ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.